GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (ASX:BNO) » Definitions » Inventories, Other

Bionomics (ASX:BNO) Inventories, Other : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Bionomics Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Bionomics's other inventories for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Bionomics Inventories, Other Historical Data

The historical data trend for Bionomics's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionomics Inventories, Other Chart

Bionomics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bionomics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bionomics Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Bionomics (ASX:BNO) Business Description

Traded in Other Exchanges
Address
200 Greenhill Road, Eastwood, SA, AUS, 5063
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.

Bionomics (ASX:BNO) Headlines

From GuruFocus

USCF Adds Funds to TD Ameritrade ETF Market Center

By PRNewswire PRNewswire 08-27-2019

USCF Joins Raymond James IAD ETF No-Transaction-Fee Platform

By PRNewswire PRNewswire 08-06-2019